Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard® Brand of Products — NexGard PLUS (afoxolaner, moxidectin and pyrantel chewable tablets) — a monthly beef-flavored soft chew that protects dogs from fleas, ticks, heartworm disease, roundworms and hookworms. By combining internal and external parasite protection in a tasty, beef-flavored soft chew, NexGard® PLUS helps make monthly compliance easy and enjoyable for pets and pet owners.

“We’re committed to making it as easy as possible to care for pets, and NexGard PLUS builds on our legacy in pet health to bring one-and-done monthly parasite protection to dogs in a beef-flavored soft chew,” said Daniel Watkins, Vice President of U.S. Pet at Boehringer Ingelheim Animal Health.

With NexGard PLUS, Boehringer Ingelheim adds to its robust parasiticide portfolio, giving veterinarians the flexibility to prescribe the right products for each pet and pet owner’s needs.

Internal and external parasite threats have expanded beyond their traditional regions and seasons. Many tick species, for example, are now found in places that they didn’t exist a decade ago, and they are searching for a host whenever temperatures are above freezing. Fleas can be an ever-present risk for dogs throughout the U.S., and the heartworm disease prevalence has increased across much of the country. This is a contributing factor in the Companion Animal Parasite Council (CAPC) recommending that pet owners administer year-round broad-spectrum parasite control with efficacy against heartworm, intestinal parasites, fleas, and ticks.

Each NexGard PLUS chew has the same proven afoxolaner dose prescribed to millions of dogs in NexGard (afoxolaner), and an optimized dose of moxidectin that is proven safe and effective.

“NexGard® PLUS is the one veterinarians will want to help keep dogs protected from parasites. It offers internal and external parasite protection in a single monthly chew that dogs will enjoy, is backed by our clinic support team, and is the latest innovation in our trusted parasiticide portfolio,” said Whit Cothern, DVM, Executive Director of Veterinary Professional Services at Boehringer Ingelheim Animal Health. “Veterinarians tackle complex challenges in their clinics every day, so we are proud to offer the solutions you want and the customer care that you want — all in one place.”